Canada In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012

Product Code GMD15228
Publication Date September 2008
Publisher Global Markets Direct
Product Type Report
Pages 138
ISBN Number not applicable
Change currency
PDF £1,895.00 €2,282 $2,996 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Canada In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012

This report is an essential source for in-depth information and data relating to the Canada In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the In In vitro diagnostic dvices in Canada

Scope

  • The report provides in vitro diagnostics information broken down into detailed categories and segments in Canada.
  • Total revenues, end users
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the in vitro diagnostics devices market in Canada.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 Table of Contents
  • 1.1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in the Report
    • 3.1 In Vitro Diagnostics Devices
    • 3.2 Clinical Chemistry Test Reagents
      • 3.2.1 Laboratory Reagents
      • 3.2.2 Clinical Chemistry Calibrators and Controls
      • 3.2.3 Clinical Chemistry Rapid Tests
    • 3.3 Immunochemistry Test Reagents
      • 3.3.1 Disease Specific Markers
      • 3.3.2 Disease Specific Test Reagents
      • 3.3.3 Drug Related Testing Reagents
      • 3.3.4 Hormone Related Testing Reagents
      • 3.3.5 Immunochemistry Calibrators and Controls
      • 3.3.6 Immunochemistry Rapid Tests
    • 3.4 Blood Test Reagents
      • 3.4.1 Hematology Test Reagents
      • 3.4.2 Hemostasis Test Reagents
      • 3.4.3 Tissue Typing Reagents
      • 3.4.4 Monoclonal Antibodies
      • 3.4.5 Cytokines and Immunomodulators
      • 3.4.6 Histology and Cytology Reagents
    • 3.5 Microbiology Test Reagents
      • 3.5.1 Bacteriology Test Reagents
      • 3.5.2 Microbiology Calibrators and Controls
      • 3.5.3 Microbiology Rapid Tests
    • 3.6 Infectious Immunology Test Reagents
      • 3.6.1 Bacteriology
      • 3.6.2 Virology
      • 3.6.3 Parasitology
      • 3.6.4 Infectious Immunology Calibrators and Controls
      • 3.6.5 Infectious Immunology Rapid Tests
    • 3.7 Genetic Test Reagents
    • 3.8 Self Testing
    • 3.9 Instruments
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Expenditure
    • 4.2 Healthcare Infrastructure
    • 4.3 Healthcare Policy
    • 4.4 Canada Healthcare Trade Statistics
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification
      • 5.1.2 Conformity Assessment
      • 5.1.3 License Fee
      • 5.1.4 License Application Processing Duration
    • 5.2 Labeling and Packaging
    • 5.3 Post-Market Surveillance
  • 6 Pricing and Reimbursement
  • 7 Distribution Structure
    • 7.1 Distribution Structure
  • 8 Canada Medical Equipment Cross Market Comparison
  • 9 In Vitro Diagnostics In Canada
    • 9.1 In Vitro Diagnostics Cross Country Comparison (2000-2012)
    • 9.2 In Vitro Diagnostics, Canada, Overall Revenues, 2000-2012
    • 9.3 In Vitro Diagnostics, Canada, Company Share (2006-2007)
  • 10 Blood Test Reagents In Canada
    • 10.1 Blood Test Reagents Overall Revenue (2000-2012)
      • 10.1.1 Haematology Test Reagents Revenue (2000-2012)
      • 10.1.2 Hemostasis Test Reagents Revenue (2000-2012)
    • 10.2 Blood Test Reagents Distribution Share (2006-2007)
    • 10.3 Blood Test Reagents, Canada, Company Share (2006-2007)
  • 11 Clinical Chemistry Test Reagents In Canada
    • 11.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2012)
    • 11.2 Clinical Chemistry Test Reagents Distribution Share (2006-2007)
    • 11.3 Clinical Chemistry Test Reagents, Canada, Company Share (2006-2007)
  • 12 Genetic Test Reagents In Canada
    • 12.1 Genetic Test Reagents Overall Revenue (2000-2012)
    • 12.2 Genetic Test Reagents Distribution Share (2006-2007)
    • 12.3 Genetic Test Reagents, Canada, Company Share (2006-2007)
  • 13 Immunochemistry Test Reagents In Canada
    • 13.1 Immunochemistry Test Reagents Overall Revenue (2000-2012)
      • 13.1.1 Disease Specific Markers Revenue (2000-2012)
      • 13.1.2 Disease Specific Test Reagents Revenue (2000-2012)
      • 13.1.3 Drug Related Testing Reagents Revenue (2000-2012)
      • 13.1.4 Hormone Related Testing Reagents Revenue (2000-2012)
    • 13.2 Immunochemistry Test Reagents Distribution Share (2006-2007)
    • 13.3 Immunochemistry Test Reagents, Canada, Company Share (2006-2007)
  • 14 Infectious Immunology Test Reagents In Canada
    • 14.1 Infectious Immunology Test Reagents Overall Revenue (2000-2012)
      • 14.1.1 Virology Revenue (2000-2012)
    • 14.2 Infectious Immunology Test Reagents Distribution Share (2006-2007)
    • 14.3 Infectious Immunology Test Reagents, Canada, Company Share (2006-2007)
  • 15 Instruments In Canada
    • 15.1 Instruments Overall Revenue (2000-2012)
    • 15.2 Instruments Distribution Share (2006-2007)
    • 15.3 Instruments, Canada, Company Share (2006-2007)
  • 16 Microbiology Test Reagents In Canada
    • 16.1 Microbiology Test Reagents Overall Revenue (2000-2012)
      • 16.1.1 Bacteriology Test Reagents Revenue (2000-2012)
    • 16.2 Microbiology Test Reagents Distribution Share (2006-2007)
    • 16.3 Microbiology Test Reagents, Canada, Company Share (2006-2007)
  • 17 Self Testing In Canada
    • 17.1 Self Testing Overall Revenue (2000-2012)
    • 17.2 Self Testing Distribution Share (2006-2007)
    • 17.3 Self Testing, Canada, Company Share (2006-2007)
  • 18 F. Hoffmann-La Roche Ltd. Company Profile
    • 18.1 Company Overview
    • 18.2 Value Chain Analysis
      • 18.2.1 Manufacturing
      • 18.2.2 Product Development
      • 18.2.3 Sales and Marketing
  • 19 Beckman Coulter, Inc. Company Profile
    • 19.1 Company Overview
    • 19.2 Value Chain Analysis
      • 19.2.1 Manufacturing
      • 19.2.2 Product Development
      • 19.2.3 Sales and Marketing
    • 19.3 Beckman Coulter, Inc. Pipeline Products
      • 19.3.1 Beckman Coulter, Inc. Pipeline Products by Equipment Type
      • 19.3.2 Beckman Coulter, Inc. Pipeline Products by Development Stage
      • 19.3.3 Beckman Coulter, Inc. Pipeline Products by Therapy Area
      • 19.3.4 Beckman Coulter, Inc. Pipeline Products by News Summary
  • 20 Dade Behring Holdings, Inc. Company Profile
    • 20.1 Company Overview
    • 20.2 Dade Behring Holdings, Inc. Pipeline Products
      • 20.2.1 Dade Behring Holdings, Inc. Pipeline Products by Equipment Type
      • 20.2.2 Dade Behring Holdings, Inc. Pipeline Products by Development Stage
      • 20.2.3 Dade Behring Holdings, Inc. Pipeline Products by Therapy Area
      • 20.2.4 Dade Behring Holdings, Inc. Pipeline Products by News Summary
  • 21 Abbott Laboratories Company Profile
    • 21.1 Company Overview
    • 21.2 Value Chain Analysis
      • 21.2.1 Manufacturing
      • 21.2.2 Product Development
      • 21.2.3 Sales and Marketing
    • 21.3 Abbott Laboratories Pipeline Products
      • 21.3.1 Abbott Laboratories Pipeline Products by Equipment Type
      • 21.3.2 Abbott Laboratories Pipeline Products by Development Stage
      • 21.3.3 Abbott Laboratories Pipeline Products by Therapy Area
      • 21.3.4 Abbott Laboratories Pipeline Products by Clinical Trials
      • 21.3.5 Abbott Laboratories Pipeline Products by News Summary
  • 22 Siemens Medical Solutions Company Profile
    • 22.1 Company Overview
    • 22.2 Value Chain Analysis
      • 22.2.1 Manufacturing
      • 22.2.2 Product Development
      • 22.2.3 Sales and Marketing
    • 22.3 Siemens Medical Solutions Pipeline Products
      • 22.3.1 Siemens Medical Solutions Pipeline Products by Equipment Type
      • 22.3.2 Siemens Medical Solutions Pipeline Products by Development Stage
      • 22.3.3 Siemens Medical Solutions Pipeline Products by Therapy Area
      • 22.3.4 Siemens Medical Solutions Pipeline Products by News Summary
  • 23 bioMerieux S.A. Company Profile
    • 23.1 Company Overview
    • 23.2 Value Chain Analysis
      • 23.2.1 Manufacturing
      • 23.2.2 Product Development
      • 23.2.3 Sales and Marketing
  • 24 Affinity Biologicals Incorporated Company Profile
    • 24.1 Company Overview
  • 25 Biocore Systems Inc. Company Profile
    • 25.1 Company Overview
  • 26 bioLytical Laboratories Inc. Company Profile
    • 26.1 Company Overview
    • 26.2 bioLytical Laboratories Inc. Pipeline Products
      • 26.2.1 bioLytical Laboratories Inc. Pipeline Products by Equipment Type
      • 26.2.2 bioLytical Laboratories Inc. Pipeline Products by Development Stage
      • 26.2.3 bioLytical Laboratories Inc. Pipeline Products By Therapy Area
      • 26.2.4 bioLytical Laboratories Inc. Pipeline Products By Clinical Trials
      • 26.2.5 bioLytical Laboratories Inc. Pipeline Products By News Summary
  • 27 Biomedica Diagnostics Inc. Company Profile
    • 27.1 Company Overview
  • 28 Cedarlane Laboratories Limited Company Profile
    • 28.1 Company Overview
  • 29 Diagnostics Chemicals Limited Company Profile
    • 29.1 Company Overview
  • 30 DRAXIMAGE Company Profile
    • 30.1 Company Overview
  • 31 Medicorp Inc. Company Profile
    • 31.1 Company Overview
  • 32 Medmira Inc. Company Profile
    • 32.1 Company Overview
  • 33 Financial Deals Landscape
    • 33.1 Acquisition
      • 33.1.1 Roche To Acquire ARIUS Research
    • 33.2 Venture Financing
      • 33.2.1 Adnavance Technologies Secures $5.47 Million In Series B Financing
  • 34 Recent Developments
    • 34.1 Strategy and Business Planning
      • 34.1.1 Mar 04, 2008: Biotage And McMaster Sign Two Year Extension To Molecular Imaging Development Agreement
  • 35 APPENDIX
    • 35.1 Global Markets Direct Research Methodology
    • 35.2 Coverage
    • 35.3 Secondary Research
    • 35.4 Primary Research
    • 35.5 Models
    • 35.6 Forecasts
    • 35.7 Expert Panels
    • 35.8 Currency Conversion
    • 35.9 Contact Us
    • 35.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Number of Physicians by Province in Canada, 2001 and 2005
    • Table 2: Hospital Wards by Specialty in Canada, 2003-2007
    • Table 3: Doctors by Specialty in Canada, 2003-2007
    • Table 4: Canada Healthcare Trade Statistics, 2001-2006
    • Table 5: Medical Equipment Classification in Canada, 2007
    • Table 6: Medical Equipment Licensing Fee in Canada, 2007
    • Table 7: Medical Equipment License Processing Duration in Canada, 2007
    • Table 8: Canada, Medical Equipment Market Comparison
    • Table 9: In Vitro Diagnostics Cross Country Comparison (2000-2012)
    • Table 10: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), 2000-2012
    • Table 11: In Vitro Diagnostics Market, Canada, Portfolio Analysis
    • Table 12: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 13: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 14: In Vitro Diagnostics, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 15: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 16: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 17: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 18: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Table 19: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 20: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Table 21: Blood Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 22: Blood Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 23: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 24: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 25: Clinical Chemistry Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 26: Clinical Chemistry Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 27: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 28: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 29: Genetic Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 30: Genetic Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 31: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 32: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 33: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 34: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Table 35: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 36: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Table 37: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 38: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Table 39: Hormone Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 40: Hormone Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Table 41: Immunochemistry Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 42: Immunochemistry Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 43: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 44: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 45: Virology, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 46: Virology, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Table 47: Infectious Immunology Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 48: Infectious Immunology Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 49: Instruments, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 50: Instruments, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 51: Instruments, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 52: Instruments, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 53: Microbiology Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 54: Microbiology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 55: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Table 56: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Table 57: Microbiology Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 58: Microbiology Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 59: Self Testing, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Table 60: Self Testing, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Table 61: Self Testing, Canada, Distribution Share by Revenue ($ mn), 2006-2007
    • Table 62: Self Testing, Canada, Company Share by Revenue ($ mn), 2006-2007
    • Table 63: Beckman Coulter, Inc. Pipeline Products by Equipment Type
    • Table 64: Beckman Coulter, Inc. Pipeline Products By Development Stage
    • Table 65: Beckman Coulter, Inc. Pipeline Products By Therapy Area
    • Table 66: Beckman Coulter, Inc. Pipeline Products By News Summaries
    • Table 67: Dade Behring Holdings, Inc. Pipeline Products by Equipment Type
    • Table 68: Dade Behring Holdings, Inc. Pipeline Products By Development Stage
    • Table 69: Dade Behring Holdings, Inc. Pipeline Products By Therapy Area
    • Table 70: Dade Behring Holdings, Inc. Pipeline Products By News Summaries
    • Table 71: Abbott Laboratories Pipeline Products by Equipment Type
    • Table 72: Abbott Laboratories Pipeline Products By Development Stage
    • Table 73: Abbott Laboratories Pipeline Products By Therapy Area
    • Table 74: Abbott Laboratories Pipeline Products By Clinical Trials
    • Table 75: Abbott Laboratories Pipeline Products By News Summaries
    • Table 76: Siemens Medical Solutions Pipeline Products by Equipment Type
    • Table 77: Siemens Medical Solutions Pipeline Products By Development Stage
    • Table 78: Siemens Medical Solutions Pipeline Products By Therapy Area
    • Table 79: Siemens Medical Solutions Pipeline Products By News Summaries
    • Table 80: bioLytical Laboratories Inc. Pipeline Products by Equipment Type
    • Table 81: bioLytical Laboratories Inc. Pipeline Products By Development Stage
    • Table 82: bioLytical Laboratories Inc. Pipeline Products By Therapy Area
    • Table 83: bioLytical Laboratories Inc. Pipeline Products By Clinical Trials
    • Table 84: bioLytical Laboratories Inc. Pipeline Products By News Summaries
    • Table 85: Currency Conversion from USD to Local Currency at 2007 Constant Rate
  • 1.2 List of Figures
    • Figure 1: Healthcare Financing in Canada, 2004
    • Figure 2: Healthcare Expenditure in Canada, 2000 - 2006
    • Figure 3: Canada, Medical Equipment Market Comparison,2007
    • Figure 4: In Vitro Diagnostics Cross Country Comparison (2000-2012)
    • Figure 5: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), 2000-2012
    • Figure 6: In Vitro Diagnostics Market, Canada, Portfolio Analysis
    • Figure 7: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 8: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 9: In Vitro Diagnostics, Canada, Company Share (%), 2007
    • Figure 10: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 11: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 12: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 13: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Figure 14: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 15: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Figure 16: Blood Test Reagents, Canada, Company Share (%), 2007
    • Figure 17: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 18: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 19: Clinical Chemistry Test Reagents, Canada, Company Share (%), 2007
    • Figure 20: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 21: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 22: Genetic Test Reagents, Canada, Company Share (%), 2007
    • Figure 23: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 24: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 25: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 26: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Figure 27: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 28: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Figure 29: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 30: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Figure 31: Hormone Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Figure 32: Immunochemistry Test Reagents, Canada, Company Share (%), 2007
    • Figure 33: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 34: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 35: Virology, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 36: Virology, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Figure 37: Infectious Immunology Test Reagents, Canada, Company Share (%), 2007
    • Figure 38: Instruments, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 39: Instruments, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 40: Instruments, Canada, Company Share (%), 2007
    • Figure 41: Microbiology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 42: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
    • Figure 43: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
    • Figure 44: Microbiology Test Reagents, Canada, Company Share (%), 2007
    • Figure 45: Self Testing, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
    • Figure 46: Self Testing, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
    • Figure 47: Self Testing, Canada, Company Share (%), 2007
    • Figure 48: F. Hoffmann-La Roche Ltd Value Chain Analysis
    • Figure 49: Beckman Coulter, Inc. Value Chain Analysis
    • Figure 50: Abbott Laboratories Value Chain Analysis
    • Figure 51: Siemens Medical Solutions Value Chain Analysis
    • Figure 52: Biomerieux Sa Value Chain Analysis
    • Figure 53: Global Markets Direct Methodology